Guidance, protocols and reports

Clostridioides difficile infection

• Protocol for the Scottish Surveillance Programme for Clostridioides difficile infection.
• Protocol for testing for Clostridioides difficile and subsequent culture.
• Protocol for the Clostridioides difficle snapshot programme.
• Guidance on Prevention and Control of Clostridium difficile Infection (CDI) in Health and Social Care Settings in Scotland.
• Clostridioides difficile infection – information for people who are getting care, their visitors, and anyone else who is in a healthcare setting.
• SAPG's updated advice on on Clostridioides difficile (C.diff) Infection (CDI).

Escherichia coli bacteraemia

• Enhanced bacteraemia surveillance protocol.

Staphylococcus aureus bacteraemia

• Enhanced bacteraemia surveillance protocol.
• Interim Advice for the Diagnosis and Management of PVL-associated Staphylococcus aureus infections (PVL-S. aureus).

Surgical site infections

• Surgical site surveillance protocol.

Quarterly epidemiological data commentaries

• Quarterly epidemiological data on Clostridioides difficile infection, Escherichia coli bacteraemia, Staphylococcus aureus bacteraemia and Surgical Site Infection in Scotland. April to June (Q2) 2024.
• Quarterly epidemiological data on Clostridioides difficile infection, Escherichia coli bacteraemia, Staphylococcus aureus bacteraemia and Surgical Site Infection in Scotland. January to March (Q1) 2024.
• Quarterly epidemiological data on Clostridioides difficile infection, Escherichia coli bacteraemia, Staphylococcus aureus bacteraemia and Surgical Site Infection in Scotland. October to December (Q4) 2023.
• Quarterly epidemiological data on Clostridioides difficile infection, Escherichia coli bacteraemia, Staphylococcus aureus bacteraemia and Surgical Site Infection in Scotland. July to September (Q3) 2023.
• Quarterly epidemiological data on Clostridioides difficile infection, Escherichia coli bacteraemia, Staphylococcus aureus bacteraemia and Surgical Site Infection in Scotland. April to June (Q2) 2023.
• Quarterly epidemiological data on Clostridioides difficile infection, Escherichia coli bacteraemia, Staphylococcus aureus bacteraemia and Surgical Site Infection in Scotland. January to March (Q1) 2023.
• Quarterly epidemiological data on Clostridioides difficile infection, Escherichia coli bacteraemia, Staphylococcus aureus bacteraemia and Surgical Site Infection in Scotland. October to December (Q4) 2022.
• Quarterly epidemiological data on Clostridioides difficile infection, Escherichia coli bacteraemia, Staphylococcus aureus bacteraemia and Surgical Site Infection in Scotland. July to September (Q3) 2022.
• Quarterly epidemiological data on Clostridioides difficile infection, Escherichia coli bacteraemia, Staphylococcus aureus bacteraemia and Surgical Site Infection in Scotland. April to June (Q2) 2022.
• Quarterly epidemiological data on Clostridioides difficile infection, Escherichia coli bacteraemia, Staphylococcus aureus bacteraemia and Surgical Site Infection in Scotland. January to March (Q1) 2022.
• Quarterly epidemiological data on Clostridioides difficile infection, Escherichia coli bacteraemia, Staphylococcus aureus bacteraemia and Surgical Site Infection in Scotland. October to December (Q4) 2021.
• Quarterly epidemiological data on Clostridioides difficile infection, Escherichia coli bacteraemia, Staphylococcus aureus bacteraemia and Surgical Site Infection in Scotland. July to September (Q3) 2021.
• Quarterly epidemiological data on Clostridioides difficile infection, Escherichia coli bacteraemia, Staphylococcus aureus bacteraemia and Surgical Site Infection in Scotland April to June 2021 (Q2) 2021.
• Quarterly epidemiological data on Clostridioides difficile infection, Escherichia coli bacteraemia, Staphylococcus aureus bacteraemia and Surgical Site Infection in Scotland January to March (Q1) 2021.
• Quarterly epidemiological data on Clostridioides difficile infection, Escherichia coli bacteraemia, Staphylococcus aureus bacteraemia and Surgical Site Infection in Scotland October to December (Q4) 2020.
• Quarterly epidemiological data on Clostridioides difficile infection, Escherichia coli bacteraemia, Staphylococcus aureus bacteraemia and Surgical Site Infection in Scotland July to September (Q3) 2020.
• Quarterly epidemiological data on Clostridioides difficile infection, Escherichia coli bacteraemia, Staphylococcus aureus bacteraemia and Surgical Site Infection in Scotland. April to June (Q2) 2020.
• Quarterly epidemiological data on Clostridioides difficile infection, Escherichia coli bacteraemia, Staphylococcus aureus bacteraemia and Surgical Site Infection in Scotland. January to March (Q1) 2020.

Exception reports

• Quarterly Epidemiological Commentary for the Surveillance of Healthcare Associated Infections in Scotland – Production of Quarterly Exception Reports (SOP).
• Report and action plan in response to Escherichia coli bacteraemia (ECB) exception.
• Report and action plan in response to Clostridioides difficile infection (CDI) exception.
• Report and action plan in response to Staphylococcus aureus bacteraemia (SAB) exception.
• Report and action plan in response to Surgical Site Infection (SSI) exception.

Protocol

• Quarterly Epidemiological Commentary for the Surveillance of Healthcare Associated Infections in Scotland – Methods & Caveats.

Open Data

• View the Open Data for this report,

Annual surveillance of Healthcare Associated Infection reports

• ARHAI Scotland 2023 Annual Report.
• ARHAI Scotland 2022 Annual Report.
• ARHAI Scotland 2021 Annual Report.
• Healthcare Associated Infections 2020 Annual Report.
• Healthcare Associated Infections 2019 Annual Report.
• Healthcare Associated Infections 2018 Annual Report.

Annual antimicrobial use and resistance in humans reports

• Scottish One Health Antimicrobial Use and Antimicrobial Resistance in 2022.
• Scottish One Health Antimicrobial Use and Antimicrobial Resistance in 2021.
• Scottish One Health Antimicrobial Use and Antimicrobial Resistance in 2020.
• Scottish One Health Antimicrobial Use and Antimicrobial Resistance in 2019.
• Scottish One Health Antimicrobial Use and Antimicrobial Resistance in 2018.

Point prevalence surveys – Hospitals

• National Point Prevalence Survey of Healthcare Associated Infection and Antimicrobial Prescribing 2016.

Point prevalence surveys – Long term care facilities

• National Point Prevalence Survey of Healthcare Associated Infection and Antimicrobial Prescribing in Long Term Care Facilities, 2017.

Surveillance of Healthcare Associated Infections in Scottish Intensive Care Units. Annual report

• Surveillance of Healthcare Associated Infections in ICU Protocol. 
• Protocol Update: PNX case definitions.
• Surveillance of Healthcare Associated Infections in Scottish Intensive Care Units. Annual report of data from January to December 2018.
• Surveillance of Healthcare Associated Infections in Scottish Intensive Care Units. Annual report of data from January to December 2017.

Weekly commentary on Hospital onset COVID-19 cases in Scotland

• All releases of Hospital onset COVID-19 cases in Scotland.

Protocol

• Hospital onset COVID-19 cases in Scotland Surveillance Protocol: January 2023.
• Hospital onset COVID-19 cases in Scotland protocol. November 2022.
• Hospital onset COVID-19 cases in Scotland protocol. January 2022.

Open Data

• View the Open Data for this report.

Quarterly commentary on Hospital onset COVID-19 mortality in Scotland

• All releases of Hospital onset COVID-19 mortality in Scotland.